MassCheck® Methylmalonic Acid Plasma Controls

Order No.: 0313/0314/0315
Methylmalonic Acid (MMA)
Grouped product items
Product Name Qty
Methylmalonic Acid Plasma Control, Level I
Order No.: 0314
Methylmalonic Acid Plasma Control, Level II
Order No.: 0315
Methylmalonic Acid Plasma Control, Bi-Level (I + II)
Order No.: 0313

MassCheck® Methylmalonic Acid Plasma Controls, lyophilised
For MassChrom® Methylmalonic Acid in Plasma/Serum (64000)

0313 MassCheck® Methylmalonic Acid Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 1 ml
0314 MassCheck® Methylmalonic Acid Plasma Control, Level I (lyoph.), 5 x 1 ml
0315 MassCheck® Methylmalonic Acid Plasma Control, Level II (lyoph.), 5 x 1 ml

These lyophilised quality controls from Chromsystems are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of methylmalonic acid in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.

More Information

Please note: Concentration values shown here are typical. For lot specific concentration values please refer to the product insert supplied with the materials. The product inserts can also be requested from us directly or downloaded from our website after login.

SubstanceUnitValue Level IRange Level IValue Level IIRange Level II
Methylmalonic acid µg/l
Method of Analysis LC-MS/MS
Storage conditions

Stored below -18 °C and unopened, the lyophilised controls are stable until the expiry date specified on the vial labels. The reconstituted controls can be stored up to 2 weeks tightly capped at +2 to +8 C. If the controls cannot be used within this period, they should be aliquoted and stored frozen below -18 °C (up to 2 months). For more details about storage conditions please check your instruction manual.

Parameter Methylmalonic Acid (MMA)
As a customer please login or register to gain full access.